Source: Cytiva
Genomic medicine is rapidly transforming healthcare, with breakthroughs in gene therapies, cell therapies, and RNA-based treatments offering new hope for previously untreatable diseases. But as innovation accelerates, manufacturing hasn’t kept pace, creating bottlenecks in scalability, cost, and speed.
This article highlights how Cytiva and industry leaders are rethinking production through advanced cell line development, process intensification, data-driven modeling, and next-generation analytics to bring these therapies to patients faster and more efficiently.
Continue reading to discover how manufacturing innovation is critical to unlocking the full potential of genomic medicine and delivering life-changing treatments at scale.
Offered Free by: Cell & Gene
See All Resources from: Cell & Gene
